Table 7 Postoperative adverse events [case (%)]
Variable | HFrEF | HFmrEF | HFpEF | Total study population |
|---|---|---|---|---|
n | 15 | 15 | 66 | 96 |
Vascular complications | 0 (0.0) | 0 (0.0) | 3 (4.5) | 3 (3.1) |
New onset CHB | 1 (6.7) | 0 (0.0) | 7 (10.6) | 8 (8.3) |
New onset LBBB | 1 (6.7) | 1 (6.7) | 14 (21.2) | 16 (16.7) |
New onset AF | 1 (6.7) | 0 (0.0) | 3 (4.5) | 4 (4.2) |
Poor wound healing | 0 (0.0) | 0 (0.0) | 1 (1.5) | 1 (1.0) |
secondary thoracotomy for hemostasis | 0 (0.0) | 0 (0.0) | 1 (1.5) | 1 (1.0) |
Coronary obstruction | 0 (0.0) | 0 (0.0) | 2 (3.0) | 2 (2.1) |
Perivalvular leakage | ||||
mild | 5 (33.3) | 2 (13.3) | 9 (13.6) | 16 (16.7) |
moderate | 1 (6.7) | 2 (13.3) | 3 (4.5) | 6 (6.3) |
Permanent pacemaker | 1 (6.7) | 0 (0.0) | 7 (10.6) | 8 (8.3) |
Stroke | 1 (6.7) | 2 (13.3) | 2 (3.0) | 5 (5.2) |
all-cause mortality | 1 (6.7) | 0 (0.0) | 2 (3.0) | 3 (3.1) |